Have questions for our experts or want more information?
Contact Us Today
Webinar Overview
Immunodeficient and humanized mouse models are driving innovation in oncology and immunology by enabling more predictive and translational preclinical studies.
Join our experts as they explore the unique capabilities of the NOD CRISPR Prkdc IL2rγ (NCG) mouse and its specialized variants. Together, we’ll show you how they can expedite your complex humanized and PDX applications.*
By the end of the presentation, you’ll learn:
- How to select suitable immunodeficient mice and rat models to match your research goals
- What sets the NCG platform apart, including its humanized and application-specific variants
- New data on solid tumor growth, body weight trends, immune cell distribution, and recent insights from a leukemic PDX study
*Not all models mentioned in the presentation are available in all geographies. Please contact us.
Webinar Presenters
Jenny Rowe, PhD
Scientist III
Charles River
Julia Schüler, DVM, PhD
Therapeutic Area Lead Oncology
Charles River